Processing....
TYSONS CORNER, VA, December 1, 2015 — The U.S. Food and Drug Administration has granted clearance to Siemens for its Multitom Robotic Advanced X-ray, which provides three-dimensional images for clinical examinations, ExecutiveBiz reported Monday. The diagnostic imaging system has two robotic arms...
The National Institute of Allergy and Infectious Diseases has awarded a division of SRI International a potential five-year, $100 million contract to develop therapies for radiation exposure. SRI Biosciences will carry out preclinical testing, good manufacturing practice development, stability studies, human clinical trials and formulation developme...
The Food and Drug Administration has awarded DSFederal a potential $20 million contract to upgrade and maintain the agency’s Safety Reporting Portal. SRP is an online data repository that gathers and distributes information on adverse events related to regulated products to the Center for Drug Ev...
SRA International has been awarded a potential five-year, $18 million contract to help develop and maintain applications and process data for a vaccine information system used by the Centers for Disease Control and Prevention and the Food and Drug Administration. The company will also carry out medical coding, clinical resear...
A Computer Sciences Corp. (NYSE: CSC) subsidiary has won a $156.6 million contract from the U.S. Army to develop an agent that protects soldiers from different types of nerve gases, Nextgov reports. Bob Brewin writes DynPort Vaccine will seek Food and Drug Administration approval for the “Bioscavenger” nerve gas prophylaxis after develop...
CACI International (NYSE: CACI) has agreed to acquire the healthcare data integration and analysis provider Emergint Technologies, with the transaction expected to close Dec. 1. CACI did not disclose the terms of the deal in its release. CACI estimates Emergint’s 2012 revenue at around $42 million and expects the transaction to increase its ea...
General Dynamics‘ (NYSE: GD) information technology business unit was awarded a position on the Omnibus III contract, which is potentially worth $497 million to all awardees, according to the company. The company said it will provide medical research support on the five-year multi-award indefinite-delivery/indefinite-quantity contract. Gener...
The U.S. government has selected Emergent BioSolutions Inc. (NYSE: EBS) to supply millions of doses of its anthrax vaccine over five years on a contract worth up to $1.25 billion. Contract work will begin this year and calls for Emergent to deliver a total of 44.75 million doses of BioThrax. In the first contract year, 8.5 million...
